Ghana vs Turkmenistan: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Turkmenistan
100.0%
in 2022
Ghana rank
1st
Turkmenistan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Turkmenistan
How they compare
Ghana currently reports 100.0% against 100.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2010 it was Turkmenistan ahead.
Ghana ranks 1st and Turkmenistan ranks 1st of 180 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.0% | 55.0% | 4.0% | Turkmenistan |
| 2020s | 97.7% | 100.0% | 2.3% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Turkmenistan?
- Ghana, at 100.0% against 100.0% in Turkmenistan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Turkmenistan?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Turkmenistan?
- 5 years are reported by both, from 2010 to 2022.
- How do Ghana and Turkmenistan rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Turkmenistan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.